Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Wider Than Expected Loss Highlights PreRevenue Challenges Telomir Pharmaceuticals Inc TELO Q4 2025 Earnings Significant EPS Miss Amid PreClinical Stage Operations AA Q1 2026 Earnings EPS Misses Estimates Shares Climb on Strategic Optimism RCUS Q1 2026 Earnings WiderThanExpected Loss as Pipeline Spending Rises FG Nexus Inc Q1 2026 Earnings Preferred Stock Reports Massive EPS Surge on Exceptional Quarterly Performance